{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-25-003309","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2025-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.841424+00:00","generated_at":"2026-05-17T06:47:25.361570+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Silexion Therapeutics prices $6.0M public offering of shares and warrants","bullets":["Raised $6.0M gross ($5.2M net) from sale of 1.5M share equivalents and warrants at $4.00/unit.","Offering includes Series A (5-year) and Series B (12-month) warrants, each exercisable at $4.00/share.","Placement agent H.C. Wainwright receives 7% cash fee plus 105,000 placement agent warrants at $5.00.","Net proceeds to fund pre-clinical studies and general corporate purposes.","Offering closed on Sept 12, 2025; securities registered under Form S-1 effective Sept 11."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-25-003309","json":"https://secwatch.observer/filing/0001178913-25-003309.json","markdown":"https://secwatch.observer/filing/0001178913-25-003309.md","text":"https://secwatch.observer/filing/0001178913-25-003309.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/0001178913-25-003309-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/zk2533780.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:47:25.361570+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}